243 related articles for article (PubMed ID: 18710402)
41. Disparate effects of phorbol esters, CD3 and the costimulatory receptors CD2 and CD28 on RANTES secretion by human T lymphocytes.
Sotsios Y; Blair PJ; Westwick J; Ward SG
Immunology; 2000 Sep; 101(1):30-7. PubMed ID: 11012750
[TBL] [Abstract][Full Text] [Related]
42. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
[TBL] [Abstract][Full Text] [Related]
43. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.
Qureshi OS; Zheng Y; Nakamura K; Attridge K; Manzotti C; Schmidt EM; Baker J; Jeffery LE; Kaur S; Briggs Z; Hou TZ; Futter CE; Anderson G; Walker LS; Sansom DM
Science; 2011 Apr; 332(6029):600-3. PubMed ID: 21474713
[TBL] [Abstract][Full Text] [Related]
44. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.
Cefai D; Cai YC; Hu H; Rudd C
Int Immunol; 1996 Oct; 8(10):1609-16. PubMed ID: 8921441
[TBL] [Abstract][Full Text] [Related]
45. Multiple negative feedbacks on CD152 expression in allograft tolerance.
Tsai MK; Ho HN; Chien HF; Tzeng MC; Chen CH; Lee PH
Transplantation; 2005 Jan; 79(2):174-81. PubMed ID: 15665765
[TBL] [Abstract][Full Text] [Related]
46. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
47. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation.
Sugita S; Ng TF; Schwartzkopff J; Streilein JW
J Immunol; 2004 Apr; 172(7):4184-94. PubMed ID: 15034031
[TBL] [Abstract][Full Text] [Related]
48. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
49. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
50. Trogocytosis of CD80 and CD86 by induced regulatory T cells.
Gu P; Gao JF; D'Souza CA; Kowalczyk A; Chou KY; Zhang L
Cell Mol Immunol; 2012 Mar; 9(2):136-46. PubMed ID: 22307040
[TBL] [Abstract][Full Text] [Related]
51. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
[TBL] [Abstract][Full Text] [Related]
52. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
[TBL] [Abstract][Full Text] [Related]
53. CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
Halliday N; Williams C; Kennedy A; Waters E; Pesenacker AM; Soskic B; Hinze C; Hou TZ; Rowshanravan B; Janman D; Walker LSK; Sansom DM
Front Immunol; 2020; 11():600000. PubMed ID: 33363541
[TBL] [Abstract][Full Text] [Related]
54. Expression of CD86 on human islet endothelial cells facilitates T cell adhesion and migration.
Lozanoska-Ochser B; Klein NJ; Huang GC; Alvarez RA; Peakman M
J Immunol; 2008 Nov; 181(9):6109-16. PubMed ID: 18941200
[TBL] [Abstract][Full Text] [Related]
55. CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease.
Pinto BF; Medeiros NI; Teixeira-Carvalho A; Eloi-Santos SM; Fontes-Cal TCM; Rocha DA; Dutra WO; Correa-Oliveira R; Gomes JAS
Front Immunol; 2018; 9():454. PubMed ID: 29599775
[TBL] [Abstract][Full Text] [Related]
56. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
[TBL] [Abstract][Full Text] [Related]
57. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
[TBL] [Abstract][Full Text] [Related]
58. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
Slavik JM; Hutchcroft JE; Bierer BE
Immunol Res; 1999; 19(1):1-24. PubMed ID: 10374692
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail.
Leung HT; Bradshaw J; Cleaveland JS; Linsley PS
J Biol Chem; 1995 Oct; 270(42):25107-14. PubMed ID: 7559643
[TBL] [Abstract][Full Text] [Related]
60. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]